We hypothesized that CSPG3 and GCKR could influence NAFLD development through intermediate risk factors (waist circumference, C-reactive protein levels, galectin-3, and HDL cholesterol). The gene discussed is LGALS3; the disease is metabolic dysfunction-associated steatotic liver disease.